BeSound
BeSound is a Los Angeles-based, direct-to-consumer breast imaging company that operates retail clinics using FDA-approved photoacoustic ultrasound with AI-assisted detection, selling $350 self-pay scans to women seeking supplemental breast cancer screening.
- Company typePrivate
- Founded2025
- HeadquartersLos Angeles, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What BeSound does
BeSound (legal entity: BLOCH Quantum Imaging Solutions, Inc.) is a Los Angeles-based breast imaging company founded in 2025 by Bailey Renger, a former NASA quantum physicist, and CTO John Stanco. The company operates direct-to-consumer breast cancer screening clinics using FDA-approved photoacoustic ultrasound technology combined with proprietary AI-based image analysis, targeting women seeking supplemental screening beyond or as an alternative to mammography.
The core product is a 15-minute breast imaging scan. The underlying technology uses photoacoustic ultrasound — laser-induced detection of blood oxygenation patterns associated with tumor angiogenesis — augmented by an AI layer that assists in interpreting imaging data and identifying suspicious findings. The service is positioned as a supplemental screening modality rather than a replacement for mammography, with reported sensitivity improvements over mammography alone.
BeSound's business model is a retail clinical hybrid: company-owned physical clinics selling directly to consumers at $350 per scan on a self-pay basis, with select insurance providers also accepted. The company launched commercially in October 2025 with two Los Angeles locations (West Hollywood and Santa Monica). Growth levers include geographic expansion (New York targeted for early 2026), a planned mobile imaging van to broaden reach without fixed real estate, and selection into the Muse Capital Optima Program (April 2026). The $6.8M seed round was co-led by Overwater Ventures, Kindred Ventures, and Muse Capital.
BeSound firmographics
Firmographics- Name
- BeSound
- Legal name
- BLOCH Quantum Imaging Solutions, Inc.
- Website
- https://besoundbreast.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BeSound is a Los Angeles-based, direct-to-consumer breast imaging company that operates retail clinics using FDA-approved photoacoustic ultrasound with AI-assisted detection, selling $350 self-pay scans to women seeking supplemental breast cancer screening.
- Ownership category
- akta.pro rank
BeSound industry classification
Industry- Product category
- Breast Imaging Services
- NAICS
- Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro industry
- Women’s Imaging & Breast Health CentersUltrasound & Echography Systems
Keywords
Where BeSound is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
BeSound business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Direct-to-Consumer Breast Imaging Scans: Self-pay patients pay $350 per scan at time of booking via the BeSound app/website. Some provider partners (e.g., Ian Grady MD) accept insurance, creating a secondary reimbursement channel. BeSound operates a dual model: one provider group (Agape) does not accept insurance (self-pay only), while another (MD) accepts insurance.
- Insurance-Reimbursed Imaging: For patients whose insurance is accepted by provider partner Ian Grady MD, BeSound submits claims to insurers on behalf of the provider. Patients are responsible for co-payments, co-insurance, or deductibles. Federal healthcare programs (Medicare, Medicaid) are not accepted.
- Free Risk Assessment (Lead Generation): Free Tyrer-Cuzick risk assessment tool drives patient acquisition and risk-stratification intake, funneling higher-risk patients into paid screening ultrasound appointments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Self-pay screening ultrasound scan at $350 per appointment |
| Transaction based/ take rate | Pay-as-you-go | Insurance-covered scan through in-network provider |
| Freemium | Pay-as-you-go | Free breast cancer risk assessment |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
BeSound product offering
Product offeringCore offering
BeSound delivers radiation-free breast imaging using FDA-approved photoacoustic ultrasound (near-infrared light combined with traditional ultrasound) enhanced by AI-powered detection, sold direct-to-consumer at $350 per scan for women with dense breast tissue and women under 40. The platform also includes a free Tyrer-Cuzick breast cancer risk assessment, a self-serve patient web app for booking and results, and operates BeSound-branded retail locations in Los Angeles plus a forthcoming mobile van, while connecting patients with independent partner medical groups that provide licensed clinical interpretation.
Product overview
BeSound is a modern breast imaging company offering a technology platform that connects individuals with independent partner medical groups providing breast imaging services. The core offering is FDA-approved advanced ultrasound (ABUS/photoacoustic) breast screening combined with AI-powered detection, positioned as an alternative to mammography for women with dense breast tissue and women under 40. The platform includes a patient portal (app.besoundbreast.com) for appointment booking and results viewing, a free Tyrer-Cuzick risk assessment tool, and operates physical locations in Los Angeles with mobile unit services coming soon. The company was founded in October 2025 by former NASA quantum physicist Bailey Renger and has raised $6.8M in seed funding.
Differentiator
Problem solved
Functional benefit
Products and services
- BeSound Breast Imaging Radiation-free, pain-free 20-minute breast imaging scan using FDA-approved photoacoustic ultrasound combined with AI-powered detection, designed for women with dense breast tissue and women under 40, with results delivered in 24-48 hours through the patient dashboard.
- BeSound Risk Assessment (Tyrer-Cuzick) Free, clinically validated Tyrer-Cuzick breast cancer risk quiz that calculates individualized 10-year and lifetime risk estimates and funnels higher-risk users into paid BeSound screening appointments.
- BeSound Patient App & Web Portal Self-serve web application for booking appointments, completing intake and risk assessments, accessing scan results through a results dashboard, and managing waitlist and account activity.
Quantifiable outcome
- Detects 35.7% more breast cancers than mammography alone
- +7 more outcomes
Companies that use BeSound
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
BeSound technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
BeSound partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered flagship, minor and core.
- Muse Capital Optima ProgramflagshipBeSound was selected as one of ten women's health companies in Muse Capital's Optima Program — the first scalable health and performance platform designed for elite female athletes and sports executives, launched in partnership with Flywheel Ventures Group (providing technology) and the Red Bull Italy SailGP Team as part of SailGP's Impact League initiative. The program offers 360-degree physical and mental health support through science-backed solutions, positioning BeSound in the sports health ecosystem.
- Red Bull Italy SailGP TeamminorRed Bull Italy SailGP Team is a partner in SailGP's Impact League initiative, collaborating with Muse Capital and Flywheel Ventures on the Optima Program that includes BeSound among its ten selected women's health companies. The partnership brings athletic performance expertise and sports science network to the women's health ecosystem.
- Agape Medical Group, P.C.coreAgape Medical Group is a professional services corporation and provider partner that delivers clinical breast imaging services through BeSound's platform. Agape does not accept health insurance and operates on a self-pay model. BeSound provides the imaging technology and administrative platform; Agape provides licensed physicians, sonographers, and radiology reads.
- Ian Grady, MD, FACScoreIan Grady MD FACS is a provider partner who accepts certain in-network insurance plans, offering an insurance-billed pathway for patients whose coverage is accepted. BeSound schedules patients with MD when they have accepted insurance. MD reads ultrasound images and provides clinical services.
- Northern Valley Breast ClinicminorNorthern Valley Breast Clinic (NVBC) is referenced in the HIPAA Notice of Privacy Practice as a licensed physician and radiologist affiliate providing breast imaging interpretation services. Patients with accepted insurance through NVBC are directed to that provider's Notice of Privacy Practice.
Scale indicators7 records
Recent moves8 records
Expansion highlights5 records
BeSound competitors and assessment
Company assessmentBroad incumbents
- Siemens Healthineers: Siemens Healthineers is a global medical imaging leader with mammography and ultrasound product lines. Comparable to BeSound as a broad incumbent in the breast imaging modality space with the resources to launch competing dense-breast screening offerings if the category gains traction.
- Hologic: Hologic is the dominant incumbent in mammography (3D tomosynthesis) and broader women's health imaging and diagnostics. Comparable as the legacy breast imaging category leader whose installed base and hospital relationships represent the competitive incumbent against BeSound's DTC ultrasound offering.
- GE HealthCare: GE HealthCare is a global medical imaging incumbent with a substantial mammography and women's health portfolio. Comparable as a broad incumbent whose R&D scale, distribution channels, and existing dense-breast screening offerings position it as the most credible large-scale competitive threat to BeSound.
Direct peers
- Ezra: Ezra is a direct-to-consumer full-body MRI startup offering pay-out-of-pocket cancer and disease screening scans in retail locations. Highly comparable to BeSound in DTC premium imaging business model, retail location strategy, and self-pay price-transparent positioning targeting proactive health-conscious consumers.
- QT Ultrasound: QT Ultrasound develops and operates FDA-cleared transmission ultrasound breast imaging as a radiation-free alternative to mammography. Directly comparable to BeSound as a breast ultrasound modality competitor focused on dense-breast and supplemental screening applications.
- Delphinus Medical Technologies: Delphinus developed SoftVue, an FDA-cleared automated whole-breast ultrasound system for supplemental dense-breast screening. A modality peer to BeSound's photoacoustic ultrasound, targeting the same clinical gap in dense-breast cancer detection.
- Prenuvo: Prenuvo is a DTC whole-body MRI screening startup emphasizing early cancer detection in a premium, wellness-oriented consumer experience. Closely comparable to BeSound on DTC imaging business model, premium self-pay pricing, retail storefront delivery, and proactive-health positioning for an affluent consumer base.
Emerging players
- Neko Health: Neko Health is a DTC preventive body-scanning startup offering AI-augmented full-body imaging in a premium consumer retail experience. Comparable to BeSound in DTC premium imaging business model, AI-driven diagnostics, and consumer-brand-led approach to preventive screening.
- iCAD: iCAD provides AI-powered breast imaging analytics (ProFound AI for DBT) and risk-stratification solutions used alongside mammography. Comparable to BeSound as a technology peer in AI-driven breast imaging interpretation, though operating as a vendor to incumbent imaging centers rather than a DTC operator.
- SonoCiné: SonoCiné provides automated whole-breast ultrasound systems (AWBUS) deployed in clinics as a supplemental screening modality for dense breast tissue. Comparable to BeSound in targeting the dense-breast screening gap with ultrasound-based technology, though distributed through partner clinics rather than DTC.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
BeSound social profiles
Digital presenceBeSound compliance and trust
Trust signalCompliance1 record
BeSound financial estimates
Financial estimateRevenue estimate
Valuation estimate
BeSound leadership team
Management profileNumber of profiles
Profiles8 records
BeSound funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BeSound M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BeSound
What does BeSound do?
BeSound delivers radiation-free breast imaging using FDA-approved photoacoustic ultrasound (near-infrared light combined with traditional ultrasound) enhanced by AI-powered detection, sold direct-to-consumer at $350 per scan for women with dense breast tissue and women under 40. The platform also includes a free Tyrer-Cuzick breast cancer risk assessment, a self-serve patient web app for booking and results, and operates BeSound-branded retail locations in Los Angeles plus a forthcoming mobile van, while connecting patients with independent partner medical groups that provide licensed clinical interpretation.
Is BeSound a public or private company?
BeSound is a private company. It is classified as venture growth investor backed and is currently operating.
When was BeSound founded?
BeSound was founded in 2025. It employs 11 to 50 people.
Where is BeSound based?
BeSound is headquartered in Los Angeles, United States, in the North America region.
How does BeSound make money?
Three revenue lines are on record. Direct-to-Consumer Breast Imaging Scans are the primary driver. The others are insurance-Reimbursed Imaging and free Risk Assessment (Lead Generation).
Who are BeSound's main competitors?
Broad incumbents on record are Siemens Healthineers, Hologic and GE HealthCare. Direct peers are Ezra, QT Ultrasound, Delphinus Medical Technologies and Prenuvo. Emerging players are Neko Health, iCAD and SonoCiné.
Does BeSound have an API?
No public API is recorded for BeSound.
What industry is BeSound in?
BeSound's product category is Breast Imaging Services. Its primary akta.pro industry code is HLAFAJAJ, Women’s Imaging & Breast Health Centers, with a secondary code of HLAHABAD, Ultrasound & Echography Systems. Its NAICS code is 621512 and its SIC code is 8071.